Health Canada, the governing body overseeing and regulating cannabis sales, on Thursday has started accepting applications from companies seeking to produce cannabis-derived goods such as edibles, beverages and vaping products, CNN reported.
The planned enhancement is projected to be a billion-dollar boon for Canada's burgeoning cannabis businesses. But, staying true to methodical form, it's going to take some time before cannabis-infused beverages and gummies appear on store shelves.
The products are not permitted for sale until at least 60 days after the application is submitted so the necessary inspections and approvals can be conducted.
In the meantime, TerrAscend is one of the first companies that has received an amendment to its license from Health Canada to allow it to sell cannabis extracts, topicals and edibles, which, according to them, will occur from its EU-GMP certified facility in Mississauga, Ontario. Sales of TerrAscend’s new product formats will begin in December, pending Health Canada authorization. "The company submitted 15 SKUs to Health Canada, including edibles, vape pens, and cartridges, to be authorized for launch this year," the team with the company explains. "In addition, the company plans on submitting an expanded set of SKUs in the coming months."
“The addition of cannabis derivatives to our product line enables TerrAscend to better meet the needs of patients and customers, who demand safe, standardized products,” said Michael Nashat, TerrAscend’s CEO. “This approval also paves the way to bring our US brands and formulations to the Canadian market.”
For more information: